JMI Syringes & Medical Devices (DHA:JMISMDL) Altman Z2-Score: 10.02 (As of Jul. 06, 2026)


DHA:JMISMDL JMI Syringes & Medical Devices Ltd DHA:JMISMDL
75 GF Score
Price BDT144.00
View Full Analysis

What is JMI Syringes & Medical Devices Altman Z2-Score?

JMI Syringes & Medical Devices DHA:JMISMDL 75 Altman Z2-Score is 10.02 as of Jul. 06, 2026. GuruFocus rates DHA:JMISMDL with a GF Score™ of 75/100.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

JMI Syringes & Medical Devices has a Altman Z2-Score of 10.02, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for JMI Syringes & Medical Devices's Altman Z2-Score or its related term are showing as below:


JMI Syringes & Medical Devices  (DHA:JMISMDL) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


JMI Syringes & Medical Devices Altman Z2-Score Related Terms


JMI Syringes & Medical Devices Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for JMI Syringes & Medical Devices's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JMI Syringes & Medical Devices Altman Z2-Score Chart

JMI Syringes & Medical Devices Annual Data
Trend Dec15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.86 10.71 7.74 9.89 11.24

JMI Syringes & Medical Devices Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.72 11.24 12.88 10.92 10.02

DHA:JMISMDL vs ISRG, BDX, MDLN: Altman Z2-Score Comparison

For the Medical Instruments & Supplies subindustry, JMI Syringes & Medical Devices's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JMI Syringes & Medical Devices Altman Z2-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, JMI Syringes & Medical Devices's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where JMI Syringes & Medical Devices's Altman Z2-Score falls into.


DHA:JMISMDL
75GF Score
JMI Syringes & Medical Devices Ltd DHA:JMISMDL
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JMI Syringes & Medical Devices Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

JMI Syringes & Medical Devices's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.4506+3.26*0.0823+6.72*0.0566+1.05*6.1123
=10.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2025:
Total Assets was BDT3,058 Mil.
Total Current Assets was BDT1,711 Mil.
Total Current Liabilities was BDT333 Mil.
Retained Earnings was BDT252 Mil.
Pre-Tax Income was 13.37 + 50.147 + 40.017 + 66.479 = BDT170 Mil.
Interest Expense was -0.771 + -1.626 + -0.208 + -0.46 = BDT-3 Mil.
Total Liabilities was BDT430 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(1711.123 - 333.162)/3058.033
=0.4506

X2=Retained Earnings/Total Assets
=251.716/3058.033
=0.0823

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(170.013 - -3.065)/3058.033
=0.0566

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(2628.069 - 0)/429.965
=6.1123

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

JMI Syringes & Medical Devices has a Altman Z2-Score of 10.02 indicating it is in Safe Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 10.02 mean?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a Altman Z2-Score of 10.02 as of Jul. 06, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on JMI Syringes & Medical Devices and its competitors.
Is JMI Syringes & Medical Devices' Altman Z2-Score too high?
JMI Syringes & Medical Devices' current Altman Z2-Score is 10.02. The Medical Devices & Instruments industry median Altman Z2-Score is 3.48. JMI Syringes & Medical Devices' value of 10.02 is 187.9% above this industry median. Overall, JMI Syringes & Medical Devices has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does JMI Syringes & Medical Devices' Altman Z2-Score compare to ISRG and BDX?
JMI Syringes & Medical Devices' Altman Z2-Score of 10.02 can be compared against companies in the Medical Devices & Instruments industry. The industry median Altman Z2-Score is 3.48. JMI Syringes & Medical Devices' value of 10.02 is 187.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Medical Devices & Instruments company?
The median Altman Z2-Score among Medical Devices & Instruments companies is 3.48, based on 846 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JMI Syringes & Medical Devices's current Altman Z2-Score of 10.02 is 187.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on JMI Syringes & Medical Devices and its competitors. For the Medical Devices & Instruments industry, the median Altman Z2-Score is 3.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JMI Syringes & Medical Devices's current Altman Z2-Score is 10.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMI Syringes & Medical Devices stock overvalued right now?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a current Altman Z2-Score of 10.02. The current Altman Z2-Score is 10.02 and 187.9% above the Medical Devices & Instruments industry median of 3.48. JMI Syringes & Medical Devices' overall GF Score™ is 75/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For JMI Syringes & Medical Devices (DHA:JMISMDL), the current Altman Z2-Score is 10.02 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

JMI Syringes & Medical Devices Business Description

Address 117, Kazi Nazrul Islam Avenue, Unique Heights, Level-11, Ramna, Dhaka, BGD, 1217
JMI Syringes & Medical Devices Ltd is a Bangladesh-based syringe and medical device manufacturing company. It manufactures and markets disposable syringe, auto-disable syringe, needle, infusion set, scalp vein set, urine drainage bag, insulin syringe, First AID bandage, riles tube, IV Cannula, feeding tube, and Blood Lancets, and other products.
75GF Score

Get the complete analysis for DHA:JMISMDL

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT144.00
Price